MY195253A - Methods for Celiac Disease Using Lactobacillus Strains - Google Patents
Methods for Celiac Disease Using Lactobacillus StrainsInfo
- Publication number
- MY195253A MY195253A MYPI2019003890A MYPI2019003890A MY195253A MY 195253 A MY195253 A MY 195253A MY PI2019003890 A MYPI2019003890 A MY PI2019003890A MY PI2019003890 A MYPI2019003890 A MY PI2019003890A MY 195253 A MY195253 A MY 195253A
- Authority
- MY
- Malaysia
- Prior art keywords
- celiac disease
- methods
- lactobacillus
- lactobacillus strains
- dsm
- Prior art date
Links
- 208000015943 Coeliac disease Diseases 0.000 title abstract 4
- 241000186660 Lactobacillus Species 0.000 title abstract 2
- 229940039696 lactobacillus Drugs 0.000 title abstract 2
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 2
- 240000006024 Lactobacillus plantarum Species 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 abstract 1
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 229940072205 lactobacillus plantarum Drugs 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1700542.2A GB201700542D0 (en) | 2017-01-12 | 2017-01-12 | Probiotic compositions and uses thereof |
| GBGB1709731.2A GB201709731D0 (en) | 2017-06-19 | 2017-06-19 | Probiotic compositions and uses thereof |
| PCT/EP2018/050789 WO2018130667A1 (en) | 2017-01-12 | 2018-01-12 | Probiotic compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY195253A true MY195253A (en) | 2023-01-11 |
Family
ID=61386800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019003890A MY195253A (en) | 2017-01-12 | 2018-01-12 | Methods for Celiac Disease Using Lactobacillus Strains |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11166993B2 (enExample) |
| EP (1) | EP3568144B1 (enExample) |
| JP (1) | JP7089523B2 (enExample) |
| KR (1) | KR102500496B1 (enExample) |
| CN (1) | CN110177561B (enExample) |
| AU (1) | AU2018207946B2 (enExample) |
| BR (1) | BR112019014418A2 (enExample) |
| CA (1) | CA3049624A1 (enExample) |
| CL (1) | CL2019001938A1 (enExample) |
| MX (1) | MX2019008292A (enExample) |
| MY (1) | MY195253A (enExample) |
| PH (1) | PH12019501629A1 (enExample) |
| RU (1) | RU2763311C2 (enExample) |
| WO (1) | WO2018130667A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020013439A (es) * | 2018-06-18 | 2021-05-12 | Probi Ab | Composiciones probioticas y usos de las mismas. |
| IT201900014550A1 (it) * | 2019-08-09 | 2021-02-09 | Abiogen Pharma Spa | Uso di colecalciferolo come agente attivo nel trattamento della celiachia |
| CN116869141A (zh) * | 2022-05-05 | 2023-10-13 | 内蒙古一康健康发展有限责任公司 | 一种具有保健功能的益生菌复合物及其制备方法 |
| KR102845919B1 (ko) * | 2023-02-28 | 2025-08-14 | 주식회사 피엘비앤비 | 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물 |
| CN119279210A (zh) * | 2024-12-16 | 2025-01-10 | 山东健源生物科技有限公司 | 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| ZA200802934B (en) * | 2005-10-06 | 2009-09-30 | Probi Ab | Use of lactobacillus for treatment of virus infections |
| EP1951273B1 (en) | 2005-10-06 | 2014-02-12 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| PL1996696T3 (pl) | 2006-03-17 | 2017-08-31 | Probi Aktiebolag | Termostabilne szczepy Lactobacillus |
| WO2007108763A1 (en) * | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
| PT2367561E (pt) | 2008-11-30 | 2015-10-23 | Immusant Inc | Composições e métodos para o tratamento da doença celíaca |
| EP2581461B1 (en) * | 2011-10-14 | 2014-09-24 | GenMont Biotech Incorporation | Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases |
| RU2654705C2 (ru) * | 2012-06-18 | 2018-05-22 | Г.Дж. Хайнц Компани Брэндс ЛЛК | Глютенозависимые расстройства |
| AU2014250113B2 (en) * | 2013-04-03 | 2017-03-30 | Probi Ab | Probiotic strains for use in treatment or prevention of osteoporosis |
| WO2016083450A2 (en) * | 2014-11-25 | 2016-06-02 | Stichting Top Institute Food And Nutrition | New probiotic and new biomarker |
-
2018
- 2018-01-12 WO PCT/EP2018/050789 patent/WO2018130667A1/en not_active Ceased
- 2018-01-12 EP EP18707627.8A patent/EP3568144B1/en active Active
- 2018-01-12 US US16/477,259 patent/US11166993B2/en active Active
- 2018-01-12 CN CN201880006818.0A patent/CN110177561B/zh active Active
- 2018-01-12 RU RU2019121145A patent/RU2763311C2/ru active
- 2018-01-12 AU AU2018207946A patent/AU2018207946B2/en active Active
- 2018-01-12 MY MYPI2019003890A patent/MY195253A/en unknown
- 2018-01-12 KR KR1020197022803A patent/KR102500496B1/ko active Active
- 2018-01-12 BR BR112019014418A patent/BR112019014418A2/pt unknown
- 2018-01-12 JP JP2019538207A patent/JP7089523B2/ja active Active
- 2018-01-12 MX MX2019008292A patent/MX2019008292A/es unknown
- 2018-01-12 CA CA3049624A patent/CA3049624A1/en active Pending
-
2019
- 2019-07-11 CL CL2019001938A patent/CL2019001938A1/es unknown
- 2019-07-12 PH PH12019501629A patent/PH12019501629A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3568144C0 (en) | 2024-05-08 |
| EP3568144A1 (en) | 2019-11-20 |
| US11166993B2 (en) | 2021-11-09 |
| CN110177561B (zh) | 2023-09-12 |
| CL2019001938A1 (es) | 2019-09-27 |
| CA3049624A1 (en) | 2018-07-19 |
| AU2018207946A1 (en) | 2019-07-25 |
| PH12019501629A1 (en) | 2020-06-01 |
| KR102500496B1 (ko) | 2023-02-16 |
| RU2763311C2 (ru) | 2021-12-28 |
| EP3568144B1 (en) | 2024-05-08 |
| US20190358275A1 (en) | 2019-11-28 |
| AU2018207946B2 (en) | 2024-07-18 |
| RU2019121145A (ru) | 2021-02-12 |
| MX2019008292A (es) | 2019-09-16 |
| CN110177561A (zh) | 2019-08-27 |
| RU2019121145A3 (enExample) | 2021-04-26 |
| BR112019014418A2 (pt) | 2020-04-14 |
| JP7089523B2 (ja) | 2022-06-22 |
| WO2018130667A1 (en) | 2018-07-19 |
| JP2020513780A (ja) | 2020-05-21 |
| KR20190104568A (ko) | 2019-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501629A1 (en) | Probiotic compositions and uses therof | |
| EP4086336A4 (en) | STRAIN OF LACTOBACILLUS PLANTARUM, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES CONTAINING SAME | |
| MX2015014016A (es) | Cepas probioticas para uso en el tratamiento o prevencion de osteoporosis. | |
| EP4484581A3 (en) | Akkermansia muciniphila eb-amdk19 strain and use thereof | |
| EP4086334A4 (en) | LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES | |
| NZ777234A (en) | Compositions comprising bacterial strains | |
| ZA202105310B (en) | Probiotic compositions comprising lactobacillus reuteri strains and methods of use | |
| EP4257194A3 (en) | Use of microbial communities for human and animal health | |
| AU2019263623A8 (en) | Probiotic Bifidobacterium breve strain and compositions comprising said strain | |
| EP4086335A4 (en) | LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES, INCLUDING THE SAME | |
| PH12018550110B1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
| SA519400920B1 (ar) | استخدام المعززات الحيوية في علاج و/أو الوقاية من التهاب الجلد التأتبي | |
| PH12017502042A1 (en) | Dietary supplement | |
| NZ746670A (en) | Bifidobacteria for increasing lean body mass | |
| WO2018135843A3 (ko) | 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물 | |
| MX2024008818A (es) | Un producto de combinacion util para profilaxis y tratamiento de sindrome de intestino irritable. | |
| MX2021003224A (es) | Combinacion de probioticos para el tratamiento de trastornos gastrointestinales relacionados con la inflamacion. | |
| MY202532A (en) | Therapeutic uses of lactobacillus plantarum | |
| SG11202000113QA (en) | Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp243 strain and use thereof | |
| MX2021004150A (es) | Composiciones que comprenden cepas bacterianas. | |
| HUE072158T2 (hu) | Lactobacillus salivarus törzs és alkalmazása malacok elválasztás utáni hasmenésének megelõzésében és kezelésében | |
| PH12019550183A1 (en) | Treatment of infant colic | |
| MX2020007906A (es) | Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas. | |
| MX2020013860A (es) | Composiciones probioticas y sus usos. | |
| MY193625A (en) | Probiotic composition for treatment or prevention of high blood cholesterol |